2019 Friends 2019 Annual Meeting Panel 1 – Characterizing the Use of External Controls for Augmenting Randomized Control Arms and Confirming Benefit View PDF
2019 Friends 2019 Annual Meeting Panel 2 – Immuno-Oncology Combination Drug Development for Patients with Disease Progression After Initial anti-PD-(L)1 Therapy View PDF
2019 Friends 2019 Annual Meeting Panel 3 – Data Generation (and Review Considerations) for Use of a Companion Diagnostic for a Group of Oncology Therapeutic Products View PDF
2019 8th Annual Blueprint for Breakthrough – Validating Real-World Endpoints for an Evolving Regulatory Landscape View PDF
2019 An Exploratory Analysis of Real-World End Points for Assessing Outcomes Among Immunotherapy-Treated Patients With Advanced Non–Small-Cell Lung Cancer View PDF
2019 Opportunities for Combination Drug Development: Data Sources and Innovative Strategies to Assess Contribution of Components View PDF
Friends Annual Meeting 2018 – Panel 3 Whitepaper: Real-Time Oncology Review and the Assessment Aid: Increasing Review Efficiency Through Standardization and Earlier Data Access
2018 2018 Annual Meeting Panel 1: Exploring Whether a Synthetic Control Arm Can Be Derived from Historical Clinical Trials that Match Baseline Characteristics and Overall Survival Outcome of a Randomized Control Arm View PDF
